Ask AI

Text Module

Share

Program Content

Activities

  • Radioligand Tx for mCRPC
    Advances in Metastatic Castration-Resistant Prostate Cancer: Focus on Radioligand Therapies
    Text Module
    Congratulations: You achieved a completion on 04/09/2022

    Released: September 16, 2025

    Expires: March 15, 2026

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by an educational grant from Novartis Pharmaceuticals Corporation.

Novartis Pharmaceuticals Corporation